Ys. Ku et al., SINGLE CATHETER TECHNIQUE OF HEPATIC VENOUS ISOLATION AND EXTRACORPOREAL CHARCOAL HEMOPERFUSION FOR MALIGNANT LIVER-TUMORS, The American journal of surgery, 173(2), 1997, pp. 103-109
BACKGROUND: A Single catheter technique of hepatic venous isolation an
d charcoal hemoperfusion (HVI-CHP) using a 4-lumen/2-balloon (4L-2B) c
atheter was developed to perform high-dose intra-arterial chemotherapy
of the liver, Herein we report the technique, safety, and pharmacokin
etics of this system in comparison with the original double-balloon te
chnique, PATIENTS AND METHODS: Sixteen patients with malignant liver t
umors were treated by hepatic arterial infusion (HAI) with adriamycin
at a dose of 100 mg/m(2) under HVI-CHP. Seven patients underwent HVI-C
HP by the double-balloon technique (group A), in which filtered hepati
c effluent and the rest of the inferior vena caval blood were separate
ly drawn and returned to the left axillary vein. The other nine patien
ts were treated by the single catheter technique (group B). In group B
, hepatic effluent was isolated by balloon inflations and directed to
fitters through fenestrations of one major lumen of a 4L-2B catheter.
The filtered blood was returned straight to the right atrium through t
he other major lumen of the catheter, RESULTS: All patients in group A
had a smooth stepwise induction of HVI-CHP, whereas one of nine patie
nts in group B developed severe hypotension requiring interruption of
HVI. The hepatic venous flow rate in group B during HVI-CHP was signif
icantly higher than that in group A (P < 0.05). Systemic adriamycin ex
posure, as assessed by the area under the time concentration curve in
systemic serum, was significantly higher in group A compared to that i
n group B (P < 0.01). CONCLUSION: The single catheter technique is hem
odynamically tolerable and feasible in the majority of patients with m
alignant liver tumors, In view of systemic drug exposure, the single c
atheter technique is superior to the original double balloon technique
. (C) 1997 by Excerpta Medica, Inc.